Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 275

2.

p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.

Liang Y, Wu J, Stancel GM, Hyder SM.

J Steroid Biochem Mol Biol. 2005 Feb;93(2-5):173-82. Epub 2005 Jan 28.

PMID:
15860260
3.

Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms.

Huh JI, Calvo A, Stafford J, Cheung M, Kumar R, Philp D, Kleinman HK, Green JE.

Oncogene. 2005 Jan 27;24(5):790-800. Erratum in: Oncogene. 2005 Jun 9;24(25):4164.

PMID:
15592523
4.

Progestin regulation of vascular endothelial growth factor in human breast cancer cells.

Hyder SM, Murthy L, Stancel GM.

Cancer Res. 1998 Feb 1;58(3):392-5.

5.

Vascular endothelial growth factor acts in an autocrine manner in rhabdomyosarcoma cell lines and can be inhibited with all-trans-retinoic acid.

Gee MF, Tsuchida R, Eichler-Jonsson C, Das B, Baruchel S, Malkin D.

Oncogene. 2005 Dec 1;24(54):8025-37.

PMID:
16116481
6.
8.

(-)-Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor-vascular endothelial growth factor receptor axis.

Shirakami Y, Shimizu M, Adachi S, Sakai H, Nakagawa T, Yasuda Y, Tsurumi H, Hara Y, Moriwaki H.

Cancer Sci. 2009 Oct;100(10):1957-62. doi: 10.1111/j.1349-7006.2009.01241.x. Epub 2009 Jun 4.

9.

Inhibition of breast carcinoma and trophoblast cell invasiveness by vascular endothelial growth factor.

Fitzpatrick TE, Lash GE, Yanaihara A, Charnock-Jones DS, Macdonald-Goodfellow SK, Graham CH.

Exp Cell Res. 2003 Feb 15;283(2):247-55.

PMID:
12581744
10.

Autocrine vascular endothelial growth factor signalling in breast cancer. Evidence from cell lines and primary breast cancer cultures in vitro.

Weigand M, Hantel P, Kreienberg R, Waltenberger J.

Angiogenesis. 2005;8(3):197-204. Epub 2005 Nov 19.

PMID:
16328160
12.

An autocrine VEGF/VEGFR2 and p38 signaling loop confers resistance to 4-hydroxytamoxifen in MCF-7 breast cancer cells.

Aesoy R, Sanchez BC, Norum JH, Lewensohn R, Viktorsson K, Linderholm B.

Mol Cancer Res. 2008 Oct;6(10):1630-8. doi: 10.1158/1541-7786.MCR-07-2172.

13.

Pancreatic carcinoma cells express neuropilins and vascular endothelial growth factor, but not vascular endothelial growth factor receptors.

Li M, Yang H, Chai H, Fisher WE, Wang X, Brunicardi FC, Yao Q, Chen C.

Cancer. 2004 Nov 15;101(10):2341-50.

14.

Curcumin inhibits MPA-induced secretion of VEGF from T47-D human breast cancer cells.

Carroll CE, Ellersieck MR, Hyder SM.

Menopause. 2008 May-Jun;15(3):570-4. doi: 10.1097/gme.0b013e31814fae5d.

PMID:
18467956
16.

Decrease of endogenous vascular endothelial growth factor may not affect glioma cell proliferation and invasion.

Hong X, Jiang F, Kalkanis SN, Zhang ZG, Zhang X, Zheng X, Mikkelsen T, Jiang H, Chopp M.

J Exp Ther Oncol. 2007;6(3):219-29.

PMID:
17552362
17.

Vascular endothelial growth factor receptor-1 promotes migration and invasion in pancreatic carcinoma cell lines.

Wey JS, Fan F, Gray MJ, Bauer TW, McCarty MF, Somcio R, Liu W, Evans DB, Wu Y, Hicklin DJ, Ellis LM.

Cancer. 2005 Jul 15;104(2):427-38.

18.

Anti-vascular endothelial growth factor receptor-1 antagonist antibody as a therapeutic agent for cancer.

Wu Y, Zhong Z, Huber J, Bassi R, Finnerty B, Corcoran E, Li H, Navarro E, Balderes P, Jimenez X, Koo H, Mangalampalli VR, Ludwig DL, Tonra JR, Hicklin DJ.

Clin Cancer Res. 2006 Nov 1;12(21):6573-84.

19.

SU5416 and SU6668 attenuate the angiogenic effects of radiation-induced tumor cell growth factor production and amplify the direct anti-endothelial action of radiation in vitro.

Abdollahi A, Lipson KE, Han X, Krempien R, Trinh T, Weber KJ, Hahnfeldt P, Hlatky L, Debus J, Howlett AR, Huber PE.

Cancer Res. 2003 Jul 1;63(13):3755-63.

20.

Functional VEGF and VEGF receptors are expressed in human medulloblastomas.

Slongo ML, Molena B, Brunati AM, Frasson M, Gardiman M, Carli M, Perilongo G, Rosolen A, Onisto M.

Neuro Oncol. 2007 Oct;9(4):384-92. Epub 2007 Aug 17.

Supplemental Content

Support Center